| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/14/1999 | CN1044117C Compound for inhibition of HIV protease, its preparing method and its drug use |
| 07/14/1999 | CN1044092C Antigen-antibody-recombination DNA composite type vaccin |
| 07/14/1999 | CN1044089C Medicine composition with enantiomerically pure beta-D-dioxolane nucleosides as active component |
| 07/13/1999 | US5922907 A chemical intermediate phenylglycyl hydroxyethyl ester or 4-phenylglycyl hydroxyethyl ester |
| 07/13/1999 | US5922845 Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922727 Antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients |
| 07/13/1999 | US5922708 Heteroaryl-oxazolidinones |
| 07/13/1999 | US5922707 Oxazolidinone antibacterial agent with tricyclic substituents |
| 07/13/1999 | US5922684 Polyhydro derivatives of tylosine and process for their preparation |
| 07/13/1999 | US5922600 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922582 Indole alkaloid type compound 0089-D |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922344 Product for prevention of respiratory virus infection and method of use |
| 07/13/1999 | US5922328 Herpes simplex |
| 07/13/1999 | US5922327 Equine herpes virus glycoproteins |
| 07/13/1999 | US5922326 Attenuated respiratory syncytial virus vaccine compositions |
| 07/13/1999 | US5922325 Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922318 Drug protein |
| 07/13/1999 | US5922314 Skin preparation composition |
| 07/13/1999 | CA2033044C 6-substituted purine carbocyclic nucleosides |
| 07/13/1999 | CA2015828C Canine corona virus vaccine |
| 07/13/1999 | CA1340645C Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus |
| 07/12/1999 | CA2258166A1 Process for the preparation of 3-amino-pyrrolidine derivatives |
| 07/08/1999 | WO1999033989A2 Rantes mutants and therapeutic applications thereof |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033970A1 Medicinal compositions for treating or preventing influenza and novel capped oligoribonucleotides |
| 07/08/1999 | WO1999033872A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 07/08/1999 | WO1999033868A2 Human papillomavirus vaccine |
| 07/08/1999 | WO1999033850A1 NOVEL β-LACTAMASE AND DD-PEPTIDASE INHIBITORS |
| 07/08/1999 | WO1999033829A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 07/08/1999 | WO1999033822A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | WO1999033815A1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | WO1999033799A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 07/08/1999 | WO1999033793A2 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | WO1999033781A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 07/08/1999 | WO1999033488A2 Adjuvanted vaccine formulation |
| 07/08/1999 | WO1999033467A1 Method and composition of an oral preparation of itraconazole |
| 07/08/1999 | WO1999033459A1 Methods of inactivating bacteria including bacterial spores |
| 07/08/1999 | WO1999033346A1 Anti-retroviral immunogens, preparation and use |
| 07/08/1999 | WO1999020639A3 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES |
| 07/08/1999 | WO1999020305A8 Veterinary vaccines |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999019304A9 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | CA2316811A1 Anti-retroviral immunogens, preparation and use |
| 07/08/1999 | CA2316218A1 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | CA2315821A1 Acylphosphates and acylphosphonates as .beta.-lactamase and dd-peptidase inhibitors |
| 07/08/1999 | CA2315723A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315276A1 Human papillomavirus vaccine |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927722A1 Beta, Beta-disubstituted derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A |
| 07/07/1999 | EP0927719A1 Triazole derivative or salt thereof, preparation process thereof as well as pharmaceutical containing said compound |
| 07/07/1999 | EP0927255A1 Vaccine production of the bacillus anthracis protective antigen |
| 07/07/1999 | EP0927254A1 Antagonists of interleukin-15 |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927182A2 Alkylated rapamycin derivatives |
| 07/07/1999 | EP0927164A1 8-hydroxy-7-substituted quinolines as anti-viral agents |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0926956A1 Use of algae extract as antibacterial and/or antifungal agent and composition containing same |
| 07/07/1999 | EP0926954A1 Antimicrobial compositions |
| 07/07/1999 | EP0748329B1 3''-desmethoxy derivatives of erythromycin and azithromycin |
| 07/07/1999 | EP0571410B1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 07/07/1999 | EP0559774B1 Individual stereoisomers of 7- 3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 07/07/1999 | EP0527916B1 Antisense inhibitors of the human immunodeficiency virus |
| 07/07/1999 | CN1222144A Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 07/07/1999 | CN1222082A Compsns. comprising antifungal agent and acetate buffer |
| 07/07/1999 | CN1221752A Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 07/07/1999 | CN1221608A Synergistic combination of AIDS antiviral compounds and HIV inhibitor |
| 07/06/1999 | US5919941 Intermediates for the preparation of sulphonic acid salts of 4-amino-2-cyclopentene-1-carboxylic acid |
| 07/06/1999 | US5919924 Process for preparing 3-halogenated cephem derivative |
| 07/06/1999 | US5919916 6-O-alkyl derivatives of erythronolide B |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919819 Dihydropyran derivatives as viral neuraminidase inhibitors |
| 07/06/1999 | US5919807 Benzothiazoles and benzoxazoles, drugs containing them, their use and methods of preparing them |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919779 5,6-Heteroaryl-dipyrido(2,3-B:3', 2'-F) azepines and their use in the prevention or treatment of HIV infection |
| 07/06/1999 | US5919771 Urea and thiourea derivatives of glycopeptides |
| 07/06/1999 | US5919763 IL-6/SIL-6R complex for promotion of liver functions |
| 07/06/1999 | US5919756 Amides |
| 07/06/1999 | US5919701 Oligonucleotides with activity against human immunodeficiency virus |
| 07/06/1999 | US5919665 A soluble endotoxin-free recombinant fusion proteins used as immunogens; antitoxins for treatment of humans and animals |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919663 Stable purA vectors and uses therefor |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919462 Nucleic acid fragments derived from the HIV-1 virus genome, corresponding peptides and their applications as reagents for evaluation of the risk of maternofoetal transmission of HIV-1 |
| 07/06/1999 | US5919461 Nonpathogenic infectious bursal disease virus and vaccine |
| 07/06/1999 | US5919458 Immunogen comprising particles of non-infectious human immunodeficieny virus having rna packaging defects in physiologically aceptable vehicle |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |